Orthofix Medical (OFIX) Gains from Investment Securities (2018 - 2026)
Orthofix Medical (OFIX) posted Gains from Investment Securities of $750000.0 for Q1 2026, up 13.64% on a QoQ basis from $660000.0 in Q4 2025, and up 222.95% year-over-year from $232233.5 in Q1 2025.
Orthofix Medical (OFIX) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Orthofix Medical's Gains from Investment Securities history runs 9 years deep, the most recent figure standing at $750000.0 for Q1 2026.
- Quarterly Gains from Investment Securities rose 222.95% year-over-year to $750000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220000.0 (down 95.7% YoY) and the FY2025 annual result came in at -$1.1 million, down 116.52% from the prior year.
- Gains from Investment Securities was $750000.0 for Q1 2026 at Orthofix Medical, up from $660000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.1 million in Q2 2024 and bottomed at -$10.7 million in Q2 2022.
- A 5-year average of -$892666.7 and a median of -$600000.0 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities slumped 580.25% — and 2024, when it surged 346.25%.
- Orthofix Medical's Gains from Investment Securities stood at -$986000.0 in 2022, then soared by 39.15% to -$600000.0 in 2023, then surged by 215.0% to $690000.0 in 2024, then decreased by 4.35% to $660000.0 in 2025, then grew by 13.64% to $750000.0 in 2026.
- Business Quant data shows OFIX's Gains from Investment Securities at $750000.0 in Q1 2026, $660000.0 in Q4 2025, and -$427000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Orthofix Medical | 476.50 Mn | 355.63 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 750,000.00 |
| Mar 31, 2026 | 750,000.00 |
| Dec 31, 2025 | 660,000.00 |
| Dec 31, 2025 | 660,000.00 |
| Sep 30, 2025 | -427,000.00 |
| Sep 30, 2025 | -427,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Jun 30, 2025 | -763,000.00 |
| Mar 31, 2025 | -610,000.00 |
| Mar 31, 2025 | -610,000.00 |
| Dec 31, 2024 | 690,000.00 |
| Dec 31, 2024 | 690,000.00 |
| Sep 30, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 3.07 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | -600,000.00 |
| Dec 31, 2023 | -600,000.00 |